Product Images Sumatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan Succinate NDC 68071-4389 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 4389 09 s109
NuCare Pharmaceuticals, Inc is a pharmaceutical company that produces Sumatriptan Succinate tablets of 50mg. The tablets are packed as unit of use tablets and have an expiration date of 00-00. The NDC number for the product is 68071-4389-09, and the tablets are available as a high-pain reliever. The warning indicates that it should be kept out of reach of children and stored at a controlled temperature of 59-86°F.*
chemical-structure - chemical structure
Sumatriptan-figure-1 - sumatriptan figure 1
This is a figure showing the estimated probability of achieving initial headache response within 4 hours of treatment with oral sumatriptan, based on pooled data from three clinical trials. The plot displays the probability over time of obtaining headache response (no or mild pain) following treatment with sumatriptan at different doses. The average response rate is shown for each dose group over the first 240 minutes after the initial dose. Patients who did not achieve response or took rescue medication within this timeframe were censored.*
Sumatriptan-figure-2 - sumatriptan figure 2
The text describes a figure and table showing the estimated probability of patients taking a second dose of Sumatriptan Succinate or other medication to treat migraines in the 24 hours following the initial dose of the study treatment. The figure is a Kaplan-Meier plot based on data obtained in three clinical controlled trials. The plot includes patients who had no response to the initial dose, and remedication was not allowed within 2 hours postdose. It shows that the probability of taking a second dose decreases over time, with the highest probability being 100% at time zero and the lowest probability being 0% at 24 hours.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
